CALABRESE, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 1.671
NA - Nord America 816
AS - Asia 661
SA - Sud America 57
AF - Africa 11
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.221
Nazione #
IT - Italia 1.539
US - Stati Uniti d'America 756
SG - Singapore 197
CN - Cina 177
BD - Bangladesh 134
VN - Vietnam 91
BR - Brasile 36
CA - Canada 36
FR - Francia 32
FI - Finlandia 25
HK - Hong Kong 22
DE - Germania 19
GB - Regno Unito 15
AR - Argentina 13
JP - Giappone 9
IN - India 8
MX - Messico 7
NL - Olanda 6
IE - Irlanda 5
PH - Filippine 5
UA - Ucraina 5
AT - Austria 4
AU - Australia 4
NI - Nicaragua 4
PL - Polonia 4
ES - Italia 3
HN - Honduras 3
ID - Indonesia 3
MY - Malesia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
IQ - Iraq 2
KE - Kenya 2
PT - Portogallo 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
MA - Marocco 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SE - Svezia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
TR - Turchia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 3.221
Città #
Genoa 1.130
Vado Ligure 234
San Jose 153
Ashburn 95
Singapore 92
New York 52
Beijing 35
Council Bluffs 34
Lauterbourg 29
Los Angeles 26
Hanoi 24
Ho Chi Minh City 23
Boardman 21
Hong Kong 21
Chicago 19
Rome 16
Santa Clara 16
Milan 15
Frankfurt am Main 14
Lappeenranta 13
Buffalo 12
Helsinki 12
Toronto 11
Naples 9
Tokyo 9
Dallas 8
Orem 8
Hamilton 7
Phoenix 7
Bologna 6
Dublin 6
Mexico City 6
Montreal 6
Stockton 6
Atlanta 5
Da Nang 5
Haiphong 5
Strafford 5
Tianjin 5
Boston 4
Brooklyn 4
Florence 4
Kyiv 4
Las Vegas 4
Livermore 4
Memphis 4
Meshoppen 4
Orlando 4
Pensacola 4
San Francisco 4
Seattle 4
Turin 4
Vienna 4
Warsaw 4
Bari 3
Buenos Aires 3
Cardiff 3
Charlotte 3
Greensboro 3
Hinton 3
Hải Dương 3
Jersey City 3
Kansas City 3
London 3
Oklahoma City 3
Philadelphia 3
Reggio Emilia 3
Shanghai 3
Tashkent 3
Verona 3
Biên Hòa 2
Bordighera 2
Brescia 2
Brugherio 2
Cagliari 2
Can Tho 2
Catania 2
Charleston 2
Chennai 2
Duque de Caxias 2
East Brunswick 2
Endicott 2
Gresham 2
Guangzhou 2
Houston 2
Jacksonville 2
Kuala Lumpur 2
Longview 2
Managua 2
Manchester 2
Marseille 2
Miami 2
Miano 2
Milwaukee 2
Monza 2
Mumbai 2
Nairobi 2
Newark 2
Piacenza 2
Poplar 2
Totale 2.368
Nome #
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies 147
Expression of Epidermal Growth Factor receptor (EGFR) in Systemic Sclerosis patients (SSc) and Gastro-oesophageal Reflux Disease (GORD) 141
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study 127
CLINICAL AND ENDOSCOPIC-HISTOLOGICAL FEATURES OF MULTIFOCAL AND CORPUS-RESTRICTED ATROPHIC GASTRITIS PATIENTS WITH NON-CARDIA GASTRIC CANCER OR DYSPLASIA: A MULTICENTER, CROSS-SECTIONAL STUDY 124
Autoimmune chronic atrophic gastritis: association between chronic proton pump inhibitors use and more severe atrophy and gastric intestinal metaplasia 118
Esophageal motor disorders across ages: A retrospective multicentric analysis 112
Effect of hiatal hernia and esophagogastric junction morphology on esophageal motility: Evidence from high‐resolution manometry studies 97
Applying Lyon consensus criteria in the work‐up of patients with extra‐oesophageal symptoms – A multicentre retrospective study 92
Albumin-bilirubin score in non-malignant liver diseases should be properly validated 90
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation? 88
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand 87
The crohn's disease exclusion diet in adults with mild-to-moderate crohn’s disease activity: A real-world open-label randomized controlled trial 86
Evaluation of the pathophysiological association between the GERD and OSAS: Esophageal pH-monitoring results beyond Lyon criteria 85
Food Intolerances, Food Allergies and IBS: Lights and Shadows 84
Clopidogrel-Induced Eosinophilic Colitis 83
The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions 83
Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission 81
Diagnostic delay in achalasia 81
Second‐Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta‐Analysis 80
From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease 80
Evaluating Vonoprazan for the treatment of erosive GERD and heartburn associated with GERD in adults 79
Biliary reflux after bariatric surgery and after gastroesophageal surgery for gastroesophageal reflux disease 75
Endoscopic Management of Eosinophilic Esophagitis: A Narrative Review on Diagnosis and Treatment 74
Assessing the short-term prognosis of patients with cirrhosis using the DIC scores 74
Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists 71
Distribution of esophageal inflammation in patients with eosinophilic esophagitis and its impact on diagnosis and outcome 68
Safety and efficacy of venous thromboembolism prophylaxis in patients with cirrhosis: A systematic review and meta-analysis 65
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial 64
SAFETY AND EFFICACY OF ATEZOLIZUMAB/ BEVACIZUMAB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND IMPAIRED LIVER FUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS 62
Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply' 60
Diet in Inflammatory Bowel Diseases: Efficacy, Tolerability, and Microbiome Effects Toward Personalized Management 60
Exploring new noninvasive parameters to predict oesophageal varices in patients with NAFLD-associated compensated liver cirrhosis 57
Expanding Insights on Ambulatory Reflux Monitoring: Future Directions and Clinical Integration 54
Role of prokinetics in ineffective esophageal motility: A call for broader consideration and future innovations 52
Eosinophilic esophagitis is the leading cause of dysphagia in an outpatient setting 48
Is global score better than a single histological parameter for assessing microscopic esophagitis? 46
Updated treatment options for gastroesophageal reflux disease in children: practical guide for clinician 45
Dietary and Nutraceutical Interventions for Functional Dyspepsia: A Narrative Review 37
Assessment of Esophagogastric Junction Barrier Function With the Supine‐Upright Transition of the Chicago Classification Protocol 36
Abnormal Milan Score and Compromised Esophageal Mucosal Integrity Stratify Gastroesophageal Reflux Disease Severity 29
The promise and pitfalls of Emerging Potassium-Competitive Acid Blockers for the treatment of Gastroesophageal reflux disease 28
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024 27
Sustained Virologic Response and Prognosis in HCV-related Hepatocellular Carcinoma: Lessons from Complementary Cohorts 26
The Therapeutic Pipeline for Eosinophilic Esophagitis: Current Landscape and Future Directions 25
Topical Protection of Esophageal Mucosa as a New Treatment of GERD 25
Evaluation of the diagnostic accuracy of two esophageal biopsy sites compared to three in histological follow-up of eosinophilic esophagitis – A multicentric study 24
Optimizing bracnh-duct intraductal papillary mucinous neoplasms surveillance: data-driven dimensional grouping for risk stratification and cost-effectiveness. The PACMANS Study 23
Combined Lyon and Milan Scores Predict Gerd Management Outcome Better Than Either Score Alone or Their Individual Components 21
Corrigendum to “Esophageal motility disorders among elderly patients: An international multicenter study” [Digestive and Liver Disease 57 (2025) 1615-1621] 15
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility 14
Esophageal motility disorders among elderly patients: An international multicenter study 12
The Milan Score Predicts Objective Gastroesophageal Reflux Disease in Patients With Type 2 Esophagogastric Junction 9
Mean Nocturnal Baseline Impedance in Gastroesophageal Reflux Disease: Considerations on the Study by Lee et al 8
Research gaps in eosinophilic esophagitis: unanswered questions and future directions 5
Totale 3.384
Categoria #
all - tutte 10.468
article - articoli 10.468
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.936


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20236 0 0 0 0 0 0 0 3 0 0 0 3
2023/2024116 5 9 0 10 6 7 15 3 8 9 14 30
2024/2025752 39 27 35 54 86 56 68 142 40 29 95 81
2025/20262.285 152 55 213 219 184 142 241 121 200 275 204 279
2026/2027225 225 0 0 0 0 0 0 0 0 0 0 0
Totale 3.384